A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
Clinical trial NCT05810597 · COMPLETED
Trial details
- NCT number
- NCT05810597
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2023-07-17
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.